The lesson is clear: skipping steps or rushing the titration creates unnecessary discomfort and increases dropout risk
As she says they 'started eating less candy but more chow'
For GLP-1 drugs, the risks include: Increased anxiety or panic from unstable blood sugar Triggering or worsening depression Heightened risk of obsessive eating behaviors Potential for self-esteem issues or body image dysmorphia For someone already struggling with mental health, these risks are compounded making proper medical oversight essential
Clinical studies show that semaglutide leads to an average weight loss of 1015% of body weight when paired with lifestyle modifications
All-in, customers might be spending $600 - $1,000 per month on food, and thats just for one-person, let alone a whole family
The recent positive topline results from Eli Lilly and Company 's ATTAIN-MAINTAIN trial for orforglipron, however, signal a potential paradigm shift